
Weyerhaeuser - Lots...


| Price and Volume | |
|---|---|
| Recent Price | 31.68 |
| 52 Week High | 32.27 |
| 52 Week Low | 20.50 |
| Avg. Daily Vol. (Mil) | 5.58 |
| Beta (3 year) | 1.18 |
| Share Related Items | |
| Mkt Cap (Mil) | 12,072.92 |
| Shares Out (Mil) | 381.09 |
| Float (Mil) | 378.82 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 0.80 |
| Current Ratio | 1.70 |
| LT Debt/ Equity | 2.25 |
| Total Debt / Equity | 2.45 |
| Valuation Ratios | |
| Price Earnings | 21.10 |
| Price/Sales | 1.77 |
| Price/Book | 4.20 |
| Price/Cash Flow | 10.30 |
| Per Share Data | |
| Earnings | 1.50 |
| Sales | 17.94 |
| Book Value | 7.53 |
| Cash Flow | 3.07 |
| Business Summary | |
|---|---|
| Mylan, Inc. develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals. It also operates specialty business engaged in respiratory, allergy and psychiatric therapies. | |
| General Information | |
| 1500 Corporate Drive
Canonsburg, PA 15317 |
|
| www.mylan.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 20000 | |
| CEO: Heather Bresch | |
| Short Interest | |
| Current Month (Mil) | 35.55 |
| Previous Month (Mil) | 31.23 |
| Short Interest Ratio (Days) | 6.60 |
| Management Effectiveness | |
| Return on Equity | 21.60 |
| Return on Assets | 5.20 |
| Return on Investments | 6.70 |
| Profitability | |
| Gross Margin | 51.00 |
| EBIT Margin | 15.90 |
| Profit Margin | 9.10 |